Helen Chalk
VICE PRESIDENT, CLINICAL OPERATIONS

Helen Chalk

Helen Chalk joined Mythic Therapeutics in April 2023, assuming responsibility for the operational strategy and execution of the Company’s clinical trials.  Helen previously held Clinical Operations leadership roles in oncology at Mersana Therapeutics and at TESARO (GSK).  At Mersana Therapeutics Helen was Vice President, Clinical Operations, leading teams working across four ADC programs in Phases 1-3 of drug development.  At TESARO (GSK), Helen was Senior Director, Trial Management, initially managing the Immuno-Oncology team, and then going on to lead and grow the Clinical Trial Management team responsible for all outsourced oncology Phase 1-3 trials and a global managed access program.  Prior to this, Helen gained valuable experience working in clinical operations and project management roles in small, medium, and large pharmaceutical companies and at a CRO, in both oncology and other therapeutic areas.

Helen received her Bachelor of Science Degree in Human Biological Sciences at Loughborough University, UK.